"The clinical community is expressing an interest in HepaFat-Scan and the Company is pursuing opportunities to participate in a number of studies both overseas and locally which are anticipated to start in the coming quarter" - from quarterly
These studies will lead to income soon but maybe not this quarter. That depends whether we are doing the studies with a paying client or simply participation for marketing reasons.
Finally some action, page-8
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.46M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26315 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 100000 | 1 |
View Market Depth
| Last trade - 09.16am 18/11/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable